These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26823765)

  • 1. C/EBPα inhibits proliferation of breast cancer cells via a novel pathway of miR-134/CREB.
    Zhang J; Ma Y; Wang S; Chen F; Gu Y
    Int J Clin Exp Pathol; 2015; 8(11):14472-8. PubMed ID: 26823765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
    Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
    Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells.
    Ming J; Zhou Y; Du J; Fan S; Pan B; Wang Y; Fan L; Jiang J
    Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26450928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
    Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
    Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
    Sheikholeslami A; Nabiuni M; Arefian E
    Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
    Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
    Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
    Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
    Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
    Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
    Mobarra N; Shafiee A; Rad SM; Tasharrofi N; Soufi-Zomorod M; Hafizi M; Movahed M; Kouhkan F; Soleimani M
    In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):604-11. PubMed ID: 25672252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
    Shi DB; Wang YW; Xing AY; Gao JW; Zhang H; Guo XY; Gao P
    Cancer Lett; 2015 Dec; 369(2):376-85. PubMed ID: 26404754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
    Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
    Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of miR-15a on induction of apoptosis in breast cancer MCF-7 cells].
    Liu YH; Hong LQ; Yu WQ; Li XY; Zheng XY
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):827-30. PubMed ID: 22335947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
    Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
    Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
    Steven A; Leisz S; Massa C; Iezzi M; Lattanzio R; Lamolinara A; Bukur J; Müller A; Hiebl B; Holzhausen HJ; Seliger B
    Mol Cancer Res; 2013 Nov; 11(11):1462-77. PubMed ID: 24025972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
    Lin L; Liu D; Liang H; Xue L; Su C; Liu M
    Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.